Essential vitamin · Evidence and safety guide
Vitamin B6: benefits, safe dosing, P-5-P and neuropathy risk
Most people do not need a stand-alone B6 supplement.
It is useful for confirmed or likely deficiency and selected clinician-directed uses, including some isoniazid regimens and pregnancy nausea. Routine high-dose use has not shown broad longevity, heart, mood or nerve benefits and can itself cause nerve injury; P-5-P is not proven safer.1,2,3,5,8,9,10,14,21

At a glance
B6
- Overall
- Strong for correcting deficiency; narrow or uncertain for most wellness claims1,5,9,10,11,14StrongFinding: established use
- Most likely to benefit
- People with confirmed deficiency, a high-risk medicine plan or a clinician-defined dietary gap1,19,21StrongFinding: established use
- Typical adult requirement
- 1.3 mg/day at ages 19–50; 1.5 mg for women and 1.7 mg for men from age 511,21StrongFinding: established use
- Conservative self-care boundary
- NHS advice limits supplements to 10 mg/day without medical advice; EFSA's 12 mg/day UL is total intake from food and supplements2,3,4StrongFinding: established use
- Best-supported form
- Low-dose pyridoxine HCl is practical and best represented in guidelines; P-5-P has no proven outcome advantage1,3,19ModerateFinding: no meaningful benefit
- P-5-P
- An active coenzyme form, but phosphorylated B6 is dephosphorylated before absorption and is not exempt from neuropathy warnings1,3,34StrongFinding: established use
- How to take
- No loading phase and no need for fat; with or without food, using food if it reduces nausea1ModerateFinding: established use
Study findings describe groups, not a guaranteed result for one person.
Research and writing
LongevityMate Editorial Team
Editorial oversight
Lukas Dvorsky, FounderClinical review
Not yet assigned or claimed
Popular claims, checked
What supplement influencers are saying
These claims are included because people encounter them. Follower count, a podcast opinion and a personal routine are not scientific proof.
What is claimed
Evidence check
Exaggerated and unsafe. NIH reports no substantial absorption difference among supplement forms; regulators include P-5-P products in neuropathy warnings and no form-specific safe threshold is established.
What is claimed
Evidence check
Contradicted as general advice. Monotherapy evidence is not firm, carpal-tunnel reviews do not support pyridoxine, and those symptoms can be early B6 toxicity.
What is claimed
Evidence check
Unsupported and hazardous. One highly specific 600 mg/day psychiatric trial conflicts with older negative evidence and cannot justify self-treatment; the dose greatly exceeds safety limits.
What is claimed
Evidence check
Exaggerated. One five-night 240 mg trial increased recalled content but not vividness, lucid dreaming or sleep quality; the dose is unsuitable for self-use.
What is claimed
Evidence check
Mechanism is not outcome proof. Multi-B evidence is mixed and one short high-dose B6 trial is not enough for treatment or chronic-use advice.
What is claimed
Evidence check
Contradicted as an outcome claim. B-vitamin regimens can lower homocysteine, but randomized evidence did not reduce myocardial infarction or death and cannot isolate B6-specific protection.
Anecdote can start a question—not answer it
A personal experience cannot show whether the supplement caused the change, how often it works or whether it is safe for someone else.